Ionis Pharmaceuticals IncNASDAQ:IONS
- LAST PRICE38.3900
- TODAY'S CHANGE (%)-0.8700 (-2.2160%)
- Bid / Lots37.4900/ 5
- Ask / Lots39.1800/ 1
- Open / Previous Close39.1300 / 39.2600
- Day Range
- 52 Week Range
- Volume910,036
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | IONS |
|---|---|---|
| 09:32 ET | 4308 | 38.83 |
| 09:34 ET | 400 | 38.86 |
| 09:36 ET | 100 | 38.86 |
| 09:41 ET | 3969 | 38.9 |
| 09:43 ET | 2845 | 38.78 |
| 09:45 ET | 3599 | 38.725 |
| 09:48 ET | 517 | 38.72 |
| 09:50 ET | 400 | 38.66 |
| 09:52 ET | 1800 | 38.77 |
| 09:54 ET | 2300 | 38.85 |
| 09:56 ET | 1016 | 38.75 |
| 09:59 ET | 300 | 38.73 |
| 10:01 ET | 911 | 38.52 |
| 10:03 ET | 908 | 38.52 |
| 10:06 ET | 2026 | 38.55 |
| 10:08 ET | 3035 | 38.46 |
| 10:10 ET | 269 | 38.5966 |
| 10:12 ET | 365 | 38.46 |
| 10:14 ET | 1882 | 38.4 |
| 10:15 ET | 1329 | 38.31 |
| 10:17 ET | 600 | 38.37 |
| 10:19 ET | 770 | 38.425 |
| 10:21 ET | 2684 | 38.6 |
| 10:24 ET | 2007 | 38.76 |
| 10:26 ET | 1270 | 38.705 |
| 10:28 ET | 234 | 38.66 |
| 10:30 ET | 1620 | 38.58 |
| 10:32 ET | 26812 | 38.69 |
| 10:33 ET | 400 | 38.71 |
| 10:35 ET | 200 | 38.64 |
| 10:37 ET | 689 | 38.575 |
| 10:39 ET | 835 | 38.625 |
| 10:42 ET | 1709 | 38.48 |
| 10:44 ET | 309 | 38.35 |
| 10:46 ET | 3470 | 38.325 |
| 10:48 ET | 1930 | 38.315 |
| 10:50 ET | 720 | 38.3 |
| 10:51 ET | 705 | 38.33 |
| 10:53 ET | 1680 | 38.33 |
| 10:55 ET | 600 | 38.38 |
| 10:57 ET | 500 | 38.34 |
| 11:00 ET | 500 | 38.29 |
| 11:02 ET | 1099 | 38.3 |
| 11:04 ET | 1000 | 38.38 |
| 11:08 ET | 200 | 38.28 |
| 11:09 ET | 300 | 38.28 |
| 11:11 ET | 1763 | 38.35 |
| 11:13 ET | 800 | 38.32 |
| 11:15 ET | 827 | 38.35 |
| 11:20 ET | 2132 | 38.38 |
| 11:22 ET | 1360 | 38.37 |
| 11:24 ET | 891 | 38.37 |
| 11:26 ET | 1266 | 38.42 |
| 11:29 ET | 600 | 38.35 |
| 11:31 ET | 6720 | 38.395 |
| 11:33 ET | 847 | 38.465 |
| 11:36 ET | 500 | 38.52 |
| 11:38 ET | 500 | 38.54 |
| 11:40 ET | 700 | 38.58 |
| 11:42 ET | 681 | 38.63 |
| 11:44 ET | 700 | 38.615 |
| 11:45 ET | 1030 | 38.64 |
| 11:47 ET | 500 | 38.65 |
| 11:49 ET | 1021 | 38.65 |
| 11:51 ET | 532 | 38.65 |
| 11:54 ET | 200 | 38.635 |
| 11:56 ET | 2150 | 38.6 |
| 11:58 ET | 1335 | 38.58 |
| 12:00 ET | 410 | 38.6 |
| 12:02 ET | 119 | 38.58 |
| 12:03 ET | 1503 | 38.6099 |
| 12:05 ET | 300 | 38.57 |
| 12:07 ET | 1800 | 38.61 |
| 12:09 ET | 721 | 38.62 |
| 12:12 ET | 300 | 38.57 |
| 12:14 ET | 815 | 38.62 |
| 12:16 ET | 2095 | 38.6 |
| 12:18 ET | 600 | 38.595 |
| 12:20 ET | 2367 | 38.6 |
| 12:21 ET | 1000 | 38.605 |
| 12:23 ET | 1890 | 38.605 |
| 12:25 ET | 700 | 38.56 |
| 12:27 ET | 1000 | 38.565 |
| 12:30 ET | 500 | 38.57 |
| 12:32 ET | 499 | 38.575 |
| 12:34 ET | 6086 | 38.7 |
| 12:36 ET | 1394 | 38.73 |
| 12:38 ET | 1300 | 38.8 |
| 12:39 ET | 1808 | 38.87 |
| 12:41 ET | 200 | 38.815 |
| 12:43 ET | 800 | 38.79 |
| 12:45 ET | 100 | 38.775 |
| 12:48 ET | 652 | 38.785 |
| 12:50 ET | 1100 | 38.71 |
| 12:52 ET | 500 | 38.675 |
| 12:54 ET | 300 | 38.66 |
| 12:56 ET | 400 | 38.71 |
| 12:57 ET | 900 | 38.65 |
| 12:59 ET | 1592 | 38.64 |
| 01:01 ET | 423 | 38.67 |
| 01:03 ET | 900 | 38.68 |
| 01:06 ET | 642 | 38.6982 |
| 01:12 ET | 1448 | 38.71 |
| 01:14 ET | 1547 | 38.65 |
| 01:15 ET | 2012 | 38.66 |
| 01:17 ET | 3167 | 38.67 |
| 01:19 ET | 600 | 38.675 |
| 01:21 ET | 1428 | 38.69 |
| 01:24 ET | 1148 | 38.7118 |
| 01:26 ET | 600 | 38.71 |
| 01:30 ET | 795 | 38.655 |
| 01:32 ET | 2059 | 38.62 |
| 01:33 ET | 800 | 38.54 |
| 01:35 ET | 1267 | 38.58 |
| 01:37 ET | 289 | 38.6031 |
| 01:39 ET | 500 | 38.57 |
| 01:42 ET | 1543 | 38.535 |
| 01:44 ET | 15428 | 38.59 |
| 01:46 ET | 1195 | 38.61 |
| 01:48 ET | 3172 | 38.6 |
| 01:50 ET | 2255 | 38.59 |
| 01:51 ET | 2723 | 38.64 |
| 01:53 ET | 3044 | 38.67 |
| 01:55 ET | 900 | 38.715 |
| 01:57 ET | 1829 | 38.7 |
| 02:00 ET | 1755 | 38.79 |
| 02:02 ET | 3023 | 38.785 |
| 02:04 ET | 379 | 38.8099 |
| 02:06 ET | 774 | 38.82 |
| 02:08 ET | 900 | 38.825 |
| 02:09 ET | 4351 | 38.8125 |
| 02:11 ET | 856 | 38.85 |
| 02:13 ET | 2800 | 38.835 |
| 02:15 ET | 1930 | 38.85 |
| 02:18 ET | 776 | 38.885 |
| 02:20 ET | 1053 | 38.8 |
| 02:22 ET | 1500 | 38.81 |
| 02:24 ET | 800 | 38.71 |
| 02:26 ET | 887 | 38.755 |
| 02:27 ET | 800 | 38.75 |
| 02:29 ET | 1262 | 38.69 |
| 02:31 ET | 1600 | 38.69 |
| 02:33 ET | 1819 | 38.705 |
| 02:36 ET | 900 | 38.69 |
| 02:38 ET | 3687 | 38.68 |
| 02:40 ET | 1069 | 38.69 |
| 02:42 ET | 1494 | 38.675 |
| 02:44 ET | 1400 | 38.68 |
| 02:45 ET | 441 | 38.68 |
| 02:47 ET | 600 | 38.68 |
| 02:49 ET | 900 | 38.68 |
| 02:51 ET | 1400 | 38.67 |
| 02:54 ET | 700 | 38.675 |
| 02:56 ET | 2536 | 38.67 |
| 02:58 ET | 2595 | 38.6 |
| 03:00 ET | 1901 | 38.568 |
| 03:02 ET | 2691 | 38.56 |
| 03:03 ET | 1774 | 38.53 |
| 03:05 ET | 7824 | 38.5 |
| 03:07 ET | 5516 | 38.505 |
| 03:09 ET | 2600 | 38.545 |
| 03:12 ET | 2073 | 38.56 |
| 03:14 ET | 1114 | 38.555 |
| 03:16 ET | 2994 | 38.58 |
| 03:18 ET | 1100 | 38.555 |
| 03:20 ET | 3836 | 38.58 |
| 03:21 ET | 3776 | 38.585 |
| 03:23 ET | 300 | 38.51 |
| 03:25 ET | 1000 | 38.485 |
| 03:27 ET | 935 | 38.4594 |
| 03:30 ET | 3107 | 38.395 |
| 03:32 ET | 3399 | 38.39 |
| 03:34 ET | 760 | 38.37 |
| 03:36 ET | 7313 | 38.36 |
| 03:38 ET | 8868 | 38.44 |
| 03:39 ET | 2257 | 38.405 |
| 03:41 ET | 1030 | 38.405 |
| 03:43 ET | 10325 | 38.465 |
| 03:45 ET | 3200 | 38.55 |
| 03:48 ET | 7121 | 38.51 |
| 03:50 ET | 6774 | 38.525 |
| 03:52 ET | 9711 | 38.4457 |
| 03:54 ET | 17368 | 38.44 |
| 03:56 ET | 20073 | 38.475 |
| 03:57 ET | 22902 | 38.445 |
| 03:59 ET | 224280 | 38.39 |
Oct 23, 2024
Ionis to hold third quarter 2024 financial results webcast, from 7:05AM ET on Wednesday Oct 23, 2024 by Dow Jones
7:05AM ET on Wednesday Oct 23, 2024 by Dow Jones
Oct 21, 2024
Oct 9, 2024
DJ Ionis Pharmaceuticals Is Maintained at Buy by Guggenheim, from 1:25PM ET on Wednesday Oct 09, 2024 by Dow Jones
1:25PM ET on Wednesday Oct 09, 2024 by Dow Jones
Oct 3, 2024
Oct 1, 2024
DJ Ionis Gets FDA Fast-Track Designation for Zilganersen in Alexander Disease, from 7:32AM ET on Tuesday Oct 01, 2024 by Dow Jones
7:32AM ET on Tuesday Oct 01, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Ionis Pharmaceuticals Inc | 6.2B | -15.2x | --- |
Tempus AI Inc | 7.0B | -5.4x | --- |
Ultragenyx Pharmaceutical Inc | 4.8B | -7.0x | --- |
Blueprint Medicines Corp | 5.7B | -41.5x | --- |
ACADIA Pharmaceuticals Inc | 2.4B | 80.5x | --- |
CRISPR Therapeutics AG | 4.1B | -14.5x | --- |
Company Information
Ionis Pharmaceuticals, Inc. is engaged in ribonucleic acid (RNA)-targeted therapeutics. The Company has five marketed medicines and a pipeline in neurology, cardiology, and other areas of high patient need. It has nine medicines in Phase III development and multiple additional medicines in early and mid-stage development. The Company’s products include SPINRAZA, QALSODY, WAINUA, TEGSEDI and WAYLIVRA. SPINRAZA is used for the treatment of patients with spinal muscular atrophy (SMA), a progressive, debilitating and often fatal genetic disease. QALSODY is an antisense medicine that is used for the treatment of adult patients with superoxide dismutase 1 amyotrophic lateral sclerosis (SOD1-ALS), a rare, neurodegenerative disorder that causes progressive loss of motor neurons leading to death. WAINUA is a self-administered subcutaneous LIgand-Conjugated Antisense (LICA) medicine used for the treatment of adults with polyneuropathy of hereditary transthyretin-mediated amyloidosis (ATTRv-PN).
Contact Information
- Headquarters
- 2855 Gazelle CourtCARLSBAD, CA, United States 92010
- Phone
- 760-931-9200
- Fax
- 302-655-5049
Executives
- Independent Chairman of the Board
- Joseph Loscalzo
- Chief Executive Officer, Director
- Brett Monia
- Chief Financial Officer, Executive Vice President - Finance
- Elizabeth Hougen
- Executive Vice President, Chief Scientific Officer
- C. Frank Bennett
- Executive Vice President, Chief Business Officer
- Joseph Baroldi
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $6.2B |
|---|---|
Revenue (TTM) | $813.5M |
Shares Outstanding | 157.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.39 |
EPS | $-2.53 |
Book Value | $2.68 |
P/E Ratio | -15.2x |
Price/Sales (TTM) | 7.6 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -44.61% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
